{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:56:38Z","timestamp":1785524198388,"version":"3.56.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1097\/mop.0b013e32833499e5","type":"journal-article","created":{"date-parts":[[2010,1,11]],"date-time":"2010-01-11T23:44:53Z","timestamp":1263253493000},"page":"113-116","source":"Crossref","is-referenced-by-count":9,"title":["Acute tumor lysis syndrome in a 7-month-old with hepatoblastoma"],"prefix":"10.1097","volume":"22","author":[{"given":"Rachel S","family":"Bercovitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian S","family":"Greffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P","family":"Hunger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20210206","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.3324\/haematol.13290","article-title":"Consensus conference on the management of tumor lysis syndrome","volume":"93","author":"Tosi","year":"2008","journal-title":"Haematologica"},{"key":"R2-20-20210206","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1200\/JCO.2005.02.6013","article-title":"Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma","volume":"24","author":"Malogolowkin","year":"2006","journal-title":"J Clin Oncol"},{"key":"R3-20-20210206","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1200\/JCO.2007.15.0177","article-title":"Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review","volume":"26","author":"Coiffier","year":"2008","journal-title":"J Clin Oncol"},{"key":"R4-20-20210206","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3324\/haematol.12327","article-title":"Tumor lysis syndrome: current perspective","volume":"93","author":"Hochberg","year":"2008","journal-title":"Haematologica"},{"key":"R5-20-20210206","first-page":"61","article-title":"Incidence and pathogenesis of tumor lysis syndrome","volume":"147","author":"Locatelli","year":"2005","journal-title":"Contrib Nephrol"},{"key":"R6-20-20210206","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00280-002-0556-x","article-title":"Acute tumor lysis syndrome in solid tumors: a case report and review of the literature","volume":"51","author":"Baeksgaard","year":"2003","journal-title":"Cancer Chemother Pharmacol"},{"key":"R7-20-20210206","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3816\/SCT.2005.n.012","article-title":"Tumor lysis syndrome in solid tumors","volume":"2","author":"Mott","year":"2005","journal-title":"Suportive Cancer Therapy"},{"key":"R8-20-20210206","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.clon.2006.09.005","article-title":"Tumour lysis syndrome in solid tumours","volume":"18","author":"Gemici","year":"2006","journal-title":"Clin Oncol"},{"key":"R9-20-20210206","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1200\/JCO.2004.05.134","article-title":"Thymoma and tumor lysis syndrome in an adolescent","volume":"22","author":"Trobaugh-Lotrario","year":"2004","journal-title":"J Clin Oncol"},{"key":"R10-20-20210206","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1399-6576.2008.01807.x","article-title":"Tumor lysis under anesthesia in a child","volume":"53","author":"Sinha","year":"2009","journal-title":"Acta Anaesthesiologica Scandinavica"},{"key":"R11-20-20210206","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0022-3468(90)90411-2","article-title":"Fatal refractory hyperkalemia due to tumor lysis during primary resection for hepatoblastoma","volume":"25","author":"Lobe","year":"1990","journal-title":"J Pediatr Surg"},{"key":"R12-20-20210206","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00000441-200301000-00008","article-title":"Spontaneous tumor lysis syndrome in solid tumors: really a rare condition?","volume":"1","author":"Vaisban","year":"2003","journal-title":"Am J Med Sci"},{"key":"R13-20-20210206","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00277-003-0608-2","article-title":"Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma\/leukemia before and after introduction of prophylactic use of urate oxidase","volume":"82","author":"W\u00f6ssmann","year":"2003","journal-title":"Ann Hematol"},{"key":"R14-20-20210206","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1182\/blood.V97.10.2998","article-title":"A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis","volume":"97","author":"Goldman","year":"2001","journal-title":"Blood"},{"key":"R15-20-20210206","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/08998280.2005.11928082","article-title":"Rasburicase (Elitek): a novel agent for tumor lysis syndrome","volume":"18","author":"Ueng","year":"2005","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"R16-20-20210206","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.leukres.2004.09.004","article-title":"A single dose of rasburicase is sufficient for the treatment of hyperuricemia in patients receiving chemotherapy","volume":"29","author":"Liu","year":"2005","journal-title":"Leukemia Research"},{"key":"R17-20-20210206","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1592\/phco.26.2.242","article-title":"Reduced-dose rasburicase in the treatment of adults with hyperuricemia associated with malignancy","volume":"26","author":"Hutcherson","year":"2006","journal-title":"Pharmacotherapy"},{"key":"R18-20-20210206","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1600-0609.2007.01013.x","article-title":"Effective treatment and prophylaxis of hyperuricemia and impaired renal function in tumor lysis syndrome with low doses of rasburicase","volume":"80","author":"Hummel","year":"2008","journal-title":"Eur J Hematol"},{"key":"R19-20-20210206","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2004.05094.x","article-title":"Tumour lysis syndrome: new therapeutic strategies and classification","volume":"127","author":"Cairo","year":"2004","journal-title":"Br J Haematol"},{"key":"R20-20-20210206","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/0885066605278969","article-title":"Hyperkalemia: a review","volume":"20","author":"Evans","year":"2005","journal-title":"J Intensive Care Med"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0b013e32833499e5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:39:16Z","timestamp":1620963556000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-201002000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0b013e32833499e5","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}